Kiniksa Pharmaceuticals International, plc Class A (KNSA)
NASDAQ · Manufacturing · Pharmaceutical preparations
KNSA price, last 12 months
Key stats
- Previous close
- $95.05
- Open
- $95.00
- Day range
- $93.03 – $96.18
- 52-week range
- $37.02 – $99.31
- Volume
- 427.5K
- Avg volume (20 days)
- 883K
- Market cap
- $7.6B
Performance
Technicals and fundamentals
About Kiniksa Pharmaceuticals International, plc Class A
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $7.6B